Main variables	Main activity, secondary one or a tool necessary for production	Total
Companies that carry out R&D in Biotechnology	Total	1.078
Companies that carry out R&D in Biotechnology	Main	526
Companies that carry out R&D in Biotechnology	Secondary dwellings	173
Companies that carry out R&D in Biotechnology	Tool	379
%Companies according to biotechnology used: Genetic code	Total	35
%Companies according to biotechnology used: Genetic code	Main	45
%Companies according to biotechnology used: Genetic code	Secondary dwellings	22
%Companies according to biotechnology used: Genetic code	Tool	27
%Companies according to biotechnology used: Functional units	Total	42
%Companies according to biotechnology used: Functional units	Main	52
%Companies according to biotechnology used: Functional units	Secondary dwellings	37
%Companies according to biotechnology used: Functional units	Tool	30
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Total	27
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Main	34
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Secondary dwellings	22
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Tool	19
%Companies according to biotechnology used: Bioprocesses	Total	49
%Companies according to biotechnology used: Bioprocesses	Main	43
%Companies according to biotechnology used: Bioprocesses	Secondary dwellings	51
%Companies according to biotechnology used: Bioprocesses	Tool	56
%Companies according to biotechnology used: Sub-cellular organisms	Total	8
%Companies according to biotechnology used: Sub-cellular organisms	Main	12
%Companies according to biotechnology used: Sub-cellular organisms	Secondary dwellings	6
%Companies according to biotechnology used: Sub-cellular organisms	Tool	4
%Companies according to biotechnology used: Bio-computing	Total	22
%Companies according to biotechnology used: Bio-computing	Main	33
%Companies according to biotechnology used: Bio-computing	Secondary dwellings	17
%Companies according to biotechnology used: Bio-computing	Tool	9
%Companies according to biotechnology used: Nanobiotechnology	Total	14
%Companies according to biotechnology used: Nanobiotechnology	Main	19
%Companies according to biotechnology used: Nanobiotechnology	Secondary dwellings	15
%Companies according to biotechnology used: Nanobiotechnology	Tool	6
%Companies according to biotechnology used: Other	Total	12
%Companies according to biotechnology used: Other	Main	13
%Companies according to biotechnology used: Other	Secondary dwellings	14
%Companies according to biotechnology used: Other	Tool	10
%Company by field(s) of ultimate application of biotechnology use: Human Health	Total	48
%Company by field(s) of ultimate application of biotechnology use: Human Health	Main	68
%Company by field(s) of ultimate application of biotechnology use: Human Health	Secondary dwellings	39
%Company by field(s) of ultimate application of biotechnology use: Human Health	Tool	25
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Total	20
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Main	21
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Secondary dwellings	20
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Tool	19
%Company by field(s) of ultimate application of biotechnology use: Food products	Total	33
%Company by field(s) of ultimate application of biotechnology use: Food products	Main	26
%Company by field(s) of ultimate application of biotechnology use: Food products	Secondary dwellings	30
%Company by field(s) of ultimate application of biotechnology use: Food products	Tool	44
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Total	24
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Main	22
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Secondary dwellings	28
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Tool	25
%Company by field(s) of ultimate application of biotechnology use: Environment	Total	15
%Company by field(s) of ultimate application of biotechnology use: Environment	Main	12
%Company by field(s) of ultimate application of biotechnology use: Environment	Secondary dwellings	26
%Company by field(s) of ultimate application of biotechnology use: Environment	Tool	14
%Company by field(s) of ultimate application of biotechnology use: Industry	Total	14
%Company by field(s) of ultimate application of biotechnology use: Industry	Main	14
%Company by field(s) of ultimate application of biotechnology use: Industry	Secondary dwellings	20
%Company by field(s) of ultimate application of biotechnology use: Industry	Tool	9
Personnel in R&D in biotechnology (no. of persons)	Total	10.191
Personnel in R&D in biotechnology (no. of persons)	Main	5.753
Personnel in R&D in biotechnology (no. of persons)	Secondary dwellings	1.481
Personnel in R&D in biotechnology (no. of persons)	Tool	2.956
Personnel in R&D in biotechnology (no. of persons): Researchers	Total	5.774
Personnel in R&D in biotechnology (no. of persons): Researchers	Main	3.440
Personnel in R&D in biotechnology (no. of persons): Researchers	Secondary dwellings	849
Personnel in R&D in biotechnology (no. of persons): Researchers	Tool	1.485
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Total	4.417
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Main	2.314
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Secondary dwellings	632
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Tool	1.471
Personnel in R&D in biotechnology (no. of persons): women	Total	5.525
Personnel in R&D in biotechnology (no. of persons): women	Main	3.332
Personnel in R&D in biotechnology (no. of persons): women	Secondary dwellings	769
Personnel in R&D in biotechnology (no. of persons): women	Tool	1.424
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Total	3.015
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Main	1.902
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Secondary dwellings	419
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Tool	694
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Total	2.511
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Main	1.431
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Secondary dwellings	350
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Tool	730
Personnel in R&D in biotechnology (FTE)	Total	7.191,4
Personnel in R&D in biotechnology (FTE)	Main	4.611,5
Personnel in R&D in biotechnology (FTE)	Secondary dwellings	889,5
Personnel in R&D in biotechnology (FTE)	Tool	1.690,4
Personnel in R&D in biotechnology (FTE): Researchers	Total	4.276,6
Personnel in R&D in biotechnology (FTE): Researchers	Main	2.783,2
Personnel in R&D in biotechnology (FTE): Researchers	Secondary dwellings	566
Personnel in R&D in biotechnology (FTE): Researchers	Tool	927,5
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Total	2.914,7
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Main	1.828,3
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Secondary dwellings	323,5
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Tool	763
Personnel in R&D in biotechnology (FTE): women	Total	3.985,4
Personnel in R&D in biotechnology (FTE): women	Main	2.631,7
Personnel in R&D in biotechnology (FTE): women	Secondary dwellings	473,6
Personnel in R&D in biotechnology (FTE): women	Tool	880,2
Personnel in R&D in biotechnology (FTE): (women) Researchers	Total	2.234
Personnel in R&D in biotechnology (FTE): (women) Researchers	Main	1.505,4
Personnel in R&D in biotechnology (FTE): (women) Researchers	Secondary dwellings	276,8
Personnel in R&D in biotechnology (FTE): (women) Researchers	Tool	451,8
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Total	1.751,4
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Main	1.126,3
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Secondary dwellings	196,7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Tool	428,4
Internal expenditure on R&D (thousands of euros)	Total	578.171
Internal expenditure on R&D (thousands of euros)	Main	392.202
Internal expenditure on R&D (thousands of euros)	Secondary dwellings	77.155
Internal expenditure on R&D (thousands of euros)	Tool	108.814
1) By nature of the expense: Current expenses	Total	517.601
1) By nature of the expense: Current expenses	Main	345.782
1) By nature of the expense: Current expenses	Secondary dwellings	70.758
1) By nature of the expense: Current expenses	Tool	101.061
1.1) Remuneration to researchers	Total	213.755
1.1) Remuneration to researchers	Main	144.473
1.1) Remuneration to researchers	Secondary dwellings	30.720
1.1) Remuneration to researchers	Tool	38.563
1.2) Remuneration to technicians and assistants	Total	98.440
1.2) Remuneration to technicians and assistants	Main	61.637
1.2) Remuneration to technicians and assistants	Secondary dwellings	11.993
1.2) Remuneration to technicians and assistants	Tool	24.810
1.3) Other current expenses	Total	205.406
1.3) Other current expenses	Main	139.672
1.3) Other current expenses	Secondary dwellings	28.045
1.3) Other current expenses	Tool	37.689
2) By nature of the expense: Capital expenses	Total	60.570
2) By nature of the expense: Capital expenses	Main	46.420
2) By nature of the expense: Capital expenses	Secondary dwellings	6.397
2) By nature of the expense: Capital expenses	Tool	7.753
2.1) Land and buildings	Total	22.609
2.1) Land and buildings	Main	21.900
2.1) Land and buildings	Secondary dwellings	79
2.1) Land and buildings	Tool	630
2.2) Equipment and instruments	Total	36.169
2.2) Equipment and instruments	Main	23.279
2.2) Equipment and instruments	Secondary dwellings	6.254
2.2) Equipment and instruments	Tool	6.636
2.3) Acquisition of specific R+D software	Total	1.793
2.3) Acquisition of specific R+D software	Main	1.242
2.3) Acquisition of specific R+D software	Secondary dwellings	63
2.3) Acquisition of specific R+D software	Tool	488
1) By origin of the funds: National funds	Total	487.615
1) By origin of the funds: National funds	Main	312.995
1) By origin of the funds: National funds	Secondary dwellings	69.889
1) By origin of the funds: National funds	Tool	104.731
1.1) Own funds	Total	330.459
1.1) Own funds	Main	205.081
1.1) Own funds	Secondary dwellings	45.123
1.1) Own funds	Tool	80.255
1.2) From companies	Total	45.462
1.2) From companies	Main	23.837
1.2) From companies	Secondary dwellings	13.797
1.2) From companies	Tool	7.827
1.3) Public Administration funds	Total	66.189
1.3) Public Administration funds	Main	40.409
1.3) Public Administration funds	Secondary dwellings	10.721
1.3) Public Administration funds	Tool	15.060
1.4) From Universities	Total	25.148
1.4) From Universities	Main	25.101
1.4) From Universities	Secondary dwellings	32
1.4) From Universities	Tool	15
1.5) From non profit private institutions	Total	20.357
1.5) From non profit private institutions	Main	18.567
1.5) From non profit private institutions	Secondary dwellings	216
1.5) From non profit private institutions	Tool	1.575
1) By origin of the funds: Foreign funds	Total	90.556
1) By origin of the funds: Foreign funds	Main	79.207
1) By origin of the funds: Foreign funds	Secondary dwellings	7.266
1) By origin of the funds: Foreign funds	Tool	4.083
2.1) From EU programmes	Total	20.932
2.1) From EU programmes	Main	15.392
2.1) From EU programmes	Secondary dwellings	3.369
2.1) From EU programmes	Tool	2.172
2.2) Other foreign funds	Total	69.624
2.2) Other foreign funds	Main	63.816
2.2) Other foreign funds	Secondary dwellings	3.897
2.2) Other foreign funds	Tool	1.911
Purchase of R&D services in biotechnology (thousands of euros)	Total	166.022
Purchase of R&D services in biotechnology (thousands of euros)	Main	131.839
Purchase of R&D services in biotechnology (thousands of euros)	Secondary dwellings	27.652
Purchase of R&D services in biotechnology (thousands of euros)	Tool	6.530
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Total	97.455
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Main	77.835
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Secondary dwellings	14.188
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Tool	5.432
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Total	68.567
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Main	54.005
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Secondary dwellings	13.464
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Tool	1.098
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Total	46
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Main	56
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Secondary dwellings	45
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Tool	33
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Total	13
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Main	12
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Secondary dwellings	17
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Tool	13
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Total	14
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Main	14
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Secondary dwellings	19
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Tool	12
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Total	14
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Main	14
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Secondary dwellings	22
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Tool	10
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Total	17
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Main	20
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Secondary dwellings	23
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Tool	12
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Total	17
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Main	20
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Secondary dwellings	21
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Tool	11
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Total	18
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Main	18
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Secondary dwellings	23
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Tool	17
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Total	35
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Main	39
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Secondary dwellings	41
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Tool	28
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Total	49
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Main	54
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Secondary dwellings	49
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Tool	41
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Total	21
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Main	21
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Secondary dwellings	21
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Tool	21
% Companies that have requested biotechnology patents	Total	15
% Companies that have requested biotechnology patents	Main	24
% Companies that have requested biotechnology patents	Secondary dwellings	10
% Companies that have requested biotechnology patents	Tool	7
Number of patents requested	Total	526
Number of patents requested	Main	397
Number of patents requested	Secondary dwellings	72
Number of patents requested	Tool	57
% Companies with income of an international origin related to biotechnological activities	Total	26
% Companies with income of an international origin related to biotechnological activities	Main	35,9
% Companies with income of an international origin related to biotechnological activities	Secondary dwellings	12,8
% Companies with income of an international origin related to biotechnological activities	Tool	18,2
% Turnover representing income of an international origin related to biotechnological activities	Total	1,4
% Turnover representing income of an international origin related to biotechnological activities	Main	11,7
% Turnover representing income of an international origin related to biotechnological activities	Secondary dwellings	.
% Turnover representing income of an international origin related to biotechnological activities	Tool	0,9
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Total	63,8
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Main	66,2
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Secondary dwellings	73
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Tool	49,7
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Total	36,2
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Main	33,8
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Secondary dwellings	27,1
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Tool	50,3
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Total	91,6
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Main	91,3
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Secondary dwellings	64,7
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Tool	95,1
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Total	0,9
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Main	0,6
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Secondary dwellings	.
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Tool	3,1
% Income of an international origin related with activities according to the classification: Operating source abroad	Total	1,9
% Income of an international origin related with activities according to the classification: Operating source abroad	Main	1,6
% Income of an international origin related with activities according to the classification: Operating source abroad	Secondary dwellings	34,9
% Income of an international origin related with activities according to the classification: Operating source abroad	Tool	1,4
% Income of an international origin related with activities according to the classification: Other	Total	5,6
% Income of an international origin related with activities according to the classification: Other	Main	6,6
% Income of an international origin related with activities according to the classification: Other	Secondary dwellings	0,4
% Income of an international origin related with activities according to the classification: Other	Tool	0,5